Rights Issue 2022

Rights issue 2022

Information regarding the rights issue will be mainly in Swedish. For information in English, please contact ir@nanologica.com.


Right issue 2022

The Board of Directors of Nanologica AB (publ) resolved on 23 August 2022, to carry out a rights issue of approximately MSEK 94 subject to the subsequent approval of an Extraordinary General Meeting. Information regarding the Extra General Meeting can be found here.

Press release: Nanologica to Execute a Preferential Rights Issue of up to MSEK 94 to Intensify Efforts within Chromatography
Bulletin from the Extraordinary General Meeting of Nanologica AB (publ)
Press release – Outcome of the rights issue



In connection with the rights issue,  Nanologica has prepared a prospectus that was approved by the Swedish Financial Supervisory Authority on September 20, 2022 (in Swedish):

Prospekt Nanologica AB (publ), 20 september 2022
Informationsfolder företrädesemission Nanologica 2022



The below information is only available in Swedish. Please contact ir@nanologica.com for further assistance.